CClinicalTrials.gg
RecruitingNCT07747025Updated Aug 12, 2026

Nurse-Led Motivational Interviewing for Blood Pressure Control

An interventional study of Individual Motivational Interviewing and Family-Involved Motivational Interviewing in Hypertension, sponsored by Kutahya Health Sciences University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Hypertension is one of the most important risk factors for cardiovascular morbidity and mortality. Effective hypertension management requires medication adherence, lifestyle modification, regular blood pressure monitoring, and self-management behaviors. Motivational interviewing is a counseling approach that may support behavior change and improve hypertension management.

This study aims to evaluate the effects of nurse-led individual motivational interviewing and family-involved motivational interviewing on blood pressure control in patients with hypertension. The study will be conducted as a single-center, three-arm, parallel-group, randomized controlled trial. A total of 180 patients with hypertension will be randomly assigned to one of three groups: usual care, individual motivational interviewing, or family-involved motivational interviewing.

Participants in the intervention groups will receive a 6-week nurse-led motivational interviewing program. In the family-involved motivational interviewing group, a family member who supports hypertension management will also participate in the sessions. Data will be collected at baseline, 6 weeks, and 18 weeks. The primary outcome is systolic blood pressure. Secondary outcomes include diastolic blood pressure, hypertension knowledge level, treatment adherence, and hypertension self-efficacy.

Read the detailed description

The study intervention is a non-invasive, education- and counseling-based behavioral nursing intervention. Participants in the control group will continue to receive routine hypertension care and will be given a standard hypertension information brochure. Participants in the individual motivational interviewing group will receive nurse-led individual motivational interviewing sessions. Participants in the family-involved motivational interviewing group will receive the same intervention, with the participation of a family member who supports the patient's hypertension management.

The intervention content includes hypertension awareness, individual risk factors, readiness for change, hypertension knowledge, misconceptions and complications, medication adherence, treatment barriers, salt reduction, nutrition behaviors, home blood pressure monitoring, physical activity, weight control, stress management, self-efficacy, problem solving, motivation maintenance, and individualized goal evaluation. Intervention fidelity will be monitored using a session checklist.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • Hypertension
  • Blood pressure control
  • Motivational interviewing
  • Family involvement
  • Nursing intervention
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 964 are open to participants now.

This study's planned enrollment of 180 is above the median of 90 across 4,994 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Kutahya Health Sciences University is the lead sponsor of 209 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 18 years or older
  • Diagnosed with hypertension for at least 6 months
  • Using antihypertensive medication
  • Able to read and understand Turkish
  • Conscious and able to communicate
  • Providing written informed consent
  • Having at least one family member who can support hypertension management and participate in sessions when needed

Exclusion criteria

Exclusion Criteria:

  • Advanced cognitive impairment
  • Active psychiatric crisis
  • History of a serious cardiovascular event within the last 3 months
  • Terminal illness
  • Serious physical condition that may prevent regular participation in intervention sessions
  • Concurrent participation in another structured education program
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
180 participants (estimated)

Study arms

  • Active comparator
    Usual Hypertension Care With Information Brochure

    Participants in this arm will continue to receive routine hypertension care. They will also receive a standard hypertension information brochure. No structured motivational interviewing intervention will be provided.

    Behavioral: Usual Hypertension Care With Information Brochure

  • Experimental
    Nurse-Led Individual Motivational Interviewing

    Participants in this arm will receive a 6-week nurse-led individual motivational interviewing program in addition to routine hypertension care. The intervention will focus on hypertension awareness, medication adherence, lifestyle modification, home blood pressure monitoring, physical activity, stress management, self-efficacy, problem solving, and maintenance of motivation.

    Behavioral: Individual Motivational Interviewing

  • Experimental
    Nurse-Led Family-Involved Motivational Interviewing

    Participants in this arm will receive the same 6-week nurse-led motivational interviewing program in addition to routine hypertension care, with the participation of a family member who supports hypertension management. The family member may support medication adherence, salt reduction, nutrition behaviors, home blood pressure monitoring, and weekly goals.

    Behavioral: Family-Involved Motivational Interviewing

Interventions

  • BehavioralIndividual Motivational Interviewing

    The intervention is a structured 6-week nurse-led individual motivational interviewing program. Sessions will focus on hypertension awareness, individual risk factors, readiness for change, hypertension knowledge, misconceptions and complications, medication adherence, treatment barriers, salt reduction, nutrition behaviors, home blood pressure monitoring, physical activity, weight control, stress management, self-efficacy, problem solving, motivation maintenance, and individualized goal evaluation.

  • BehavioralFamily-Involved Motivational Interviewing

    The intervention is a structured 6-week nurse-led motivational interviewing program delivered with the participation of a family member who supports the patient's hypertension management. The intervention content is the same as the individual motivational interviewing program. The family member will be included to support medication adherence, salt reduction, nutrition behaviors, home blood pressure monitoring, and achievement of weekly goals.

  • BehavioralUsual Hypertension Care With Information Brochure

    Participants will continue to receive routine hypertension care and will be given a standard hypertension information brochure. No structured motivational interviewing session will be provided.

06

What researchers measure

Primary outcomes

  1. Systolic Blood Pressure

    Systolic blood pressure will be measured in mmHg using a standard blood pressure measurement procedure. Measurements will be taken after at least 5 minutes of rest using an appropriate cuff. At each assessment, at least two measurements will be taken from the same arm, and the average value will be used in the analysis. Lower systolic blood pressure values indicate better blood pressure control.

    Time frame: Baseline, 6 weeks, and 18 weeks

Secondary outcomes

  1. Diastolic Blood Pressure

    Diastolic blood pressure will be measured in mmHg using a standard blood pressure measurement procedure. Measurements will be taken after at least 5 minutes of rest using an appropriate cuff. At each assessment, at least two measurements will be taken from the same arm, and the average value will be used in the analysis. Lower diastolic blood pressure values indicate better blood pressure control.

    Time frame: Baseline, 6 weeks, and 18 weeks

  2. Hypertension Knowledge Level Assessed by the Hypertension Knowledge-Level Scale

    Hypertension knowledge level will be assessed using the Hypertension Knowledge-Level Scale. The scale includes 22 items. Total scores range from 0 to 22. Higher scores indicate a higher level of hypertension-related knowledge.

    Time frame: Baseline, 6 weeks, and 18 weeks

  3. Treatment Adherence Assessed by the Hill-Bone Hypertension Treatment Adherence Scale

    Treatment adherence will be assessed using the Hill-Bone Hypertension Treatment Adherence Scale. The scale includes 12 items. Total scores range from 12 to 48. Higher scores indicate poorer adherence to hypertension treatment, while lower scores indicate better treatment adherence.

    Time frame: Baseline, 6 weeks, and 18 weeks

  4. Hypertension Self-Efficacy Assessed by the Hypertension Self-Efficacy Scale

    Hypertension self-efficacy will be assessed using the Hypertension Self-Efficacy Scale. The scale includes 20 items. Total scores range from 20 to 80. Higher scores indicate higher hypertension self-efficacy.

    Time frame: Baseline, 6 weeks, and 18 weeks

07

Study locations

1 of 1 sites recruiting
  • Simav Doc. Dr. Ismail Karakuyu State Hospital
    Simav, Turkey (Türkiye)
    Recruiting
08

References and documents

Publications

  • Mehta SJ, Volpp KG, Troxel AB, Teel J, Reitz CR, Purcell A, Shen H, McNelis K, Snider CK, Asch DA. Remote Blood Pressure Monitoring With Social Support for Patients With Hypertension: A Randomized Clinical Trial. JAMA Netw Open. 2024 Jun 3;7(6):e2413515. doi: 10.1001/jamanetworkopen.2024.13515. PubMed 38829618 ↗
  • Khadoura KJ, Shakibazadeh E, Mansournia MA, Aljeesh Y, Fotouhi A. Effectiveness of motivational interviewing on medication adherence among Palestinian hypertensive patients: a clustered randomized controlled trial. Eur J Cardiovasc Nurs. 2021 Jun 29;20(5):411-420. doi: 10.1093/eurjcn/zvaa015. PubMed 34009313 ↗
  • Xu J, Gu X, Gu J, Zhao L, Li M, Hong C. Motivational interviewing intervention for the management of hypertension: a meta-analysis. Front Cardiovasc Med. 2025 Jan 20;11:1457039. doi: 10.3389/fcvm.2024.1457039. eCollection 2024. PubMed 39902088 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study includes health-related information from patients with hypertension. De-identified aggregate results may be reported in scientific publications.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07747025
Lead sponsor
Kutahya Health Sciences University
Responsible party
Sponsor
First posted
Aug 5, 2026
Start date
Aug 1, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 12, 2026

Study contacts

Serkan Budak, PhD / RN
Contact
serkan.budak@ksbu.edu.tr
+905385430616

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion